Prevalence and risk factors for red blood cell alloimmunisation among sickle cell patients in Mwanza City, Tanzania

African Journal of Laboratory Medicine

 
 
Field Value
 
Title Prevalence and risk factors for red blood cell alloimmunisation among sickle cell patients in Mwanza City, Tanzania
 
Creator Tebuka, Erius Charles, Mwesige Bhuko, Jeffer O.
 
Subject Health Science;Medical Laboratory sickle cell disease; alloimmunisation; alloantibody; screening cells; Bugando Medical Centre; Catholic University of Health and Allied Sciences; red blood cells
Description Background: Erythrocyte alloimmunisation can lead to complications such as delayed haemolytic transfusion reaction.Objective: This study investigated the prevalence of and risk factors for red blood cell alloimmunisation among multiply transfused sickle cell disease (SCD) patients in Mwanza City, Tanzania.Methods: From May 2017 to July 2017, this descriptive, cross-sectional, hospital-based study enrolled 200 participants with SCD who had received at least two units of blood in the previous year. Blood count was performed using a Sysmex haematology analyser. Antibody screening was done by the tube method using a panel of three screening cells with known antigenicity.Results: Of the 200 patients enrolled, 108 (54%) were female. The median age was 4.5 years (interquartile range [IQR] = 6), the median number of transfusions was 3 (IQR = 1), and the median pre-transfusion haemoglobin level was 6.6 g/dl (IQR = 2.7). Prevalence of alloimmunisation was 8.5% (17/200) with immunoglobulin G, and one patient developed cold immunoglobulin M antibodies. Blood groups reported were Rhesus C and E, Kell, Kidd and Duffy. There was no statistically significant association between the number of transfusions and the risk of alloimmunisation.Conclusion: The rate of alloimmunisation in multiply transfused SCD patients was 8.5% and higher than other studies in East Africa. Thus, there is a need for extensive red blood cell screening and matching to minimize alloimmunisation and risk of delayed haemolytic transfusion reaction, particularly in SCD and chronically transfused patients.
 
Publisher AOSIS
 
Contributor lorne lab UK,HESLB,CUHAS,Bugando Medical Centre,Erius Tebuka,Sarah Buko
Date 2020-09-10
 
Type info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion — lab experimental
Format text/html application/epub+zip text/xml application/pdf
Identifier 10.4102/ajlm.v9i1.823
 
Source African Journal of Laboratory Medicine; Vol 9, No 1 (2020); 5 pages 2225-2010 2225-2002
 
Language eng
 
Relation
The following web links (URLs) may trigger a file download or direct you to an alternative webpage to gain access to a publication file format of the published article:

https://ajlmonline.org/index.php/ajlm/article/view/823/1621 https://ajlmonline.org/index.php/ajlm/article/view/823/1620 https://ajlmonline.org/index.php/ajlm/article/view/823/1622 https://ajlmonline.org/index.php/ajlm/article/view/823/1619
 
Coverage — — blood transfusions
Rights Copyright (c) 2020 Erius Tebuka, Mwesige Charles, Jeffer O. Bhuko https://creativecommons.org/licenses/by/4.0
ADVERTISEMENT